Swiss National Bank Ginkgo Bioworks Holdings, Inc. Transaction History

Swiss National Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$0.28 - $1.16 $8,960 - $37,120	32,000 Added 1.54%	2,110,500 $696,000
Q1 2024 May 07, 2024	BUY	$1.06 - $1.67 $29,362 - $46,259	27,700 Added 1.35%	2,078,500 $2.41 Million
Q4 2023 Feb 06, 2024	SELL	$1.26 - $1.79 $269,766 - $383,239	-214,100 Reduced 9.45%	2,050,800 $3.47 Million
Q3 2023 Nov 08, 2023	BUY	$1.61 - $2.54 $344,379 - $543,306	213,900 Added 10.43%	2,264,900 $4.1 Million
Q2 2023 Aug 09, 2023	BUY	$1.14 - $1.95 $277,134 - $474,045	243,100 Added 13.45%	2,051,000 $3.81 Million
Q1 2023 May 10, 2023	SELL	$1.2 - $2.19 $207,840 - $379,308	-173,200 Reduced 8.74%	1,807,900 $2.4 Million
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $904,486 - $1.95 Million	554,900 Added 38.91%	1,981,100 $3.35 Million
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $19,272 - $98,736	26,400 Added 1.89%	1,426,200 $4.45 Million
Q2 2022 Aug 09, 2022	BUY	$2.2 - $4.2 $3.08 Million - $5.88 Million	1,399,800 New	1,399,800 $3.33 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.